The predictive value for excellent response to initial therapy in differentiated thyroid cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The predictive value for excellent response to initial therapy in differentiated thyroid cancer

Published:2018-05 Issue:5 Volume:39 Page:405-410
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Zhang Yajing,Hua Wenjuan,Zhang Xiao,Peng Jun,Liang Jiaqian,Gao Zairong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference27 articles.

1. Increasing incidence of thyroid cancer in the United States, 1973–2002;Davies;JAMA,2006

2. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea;Cho;Cancer,2015

3. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

4. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer;Cooper;Thyroid,2009

5. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer;Haugen;Thyroid,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Power of Preablation Stimulated Thyroglobulin in Children With Differentiated Thyroid Cancer;Endocrine Practice;2023-12

2. The therapeutic responses to I-131 ablation in patients of differentiated thyroid carcinoma complicated with nodular goiter;Médecine Nucléaire;2022-08

3. Prognostic Factors for Excellent Response to Initial Therapy in Patients With Papillary Thyroid Cancer From a Prospective Multicenter Study;Frontiers in Oncology;2022-07-04

4. A Retrospective Cohort Study with Validation of Predictors of Differentiated Thyroid Cancer Outcomes;Thyroid;2022-06-30

5. Preablation Stimulated Thyroglobulin as a Predictor of Persistent/Recurrent Differentiated Thyroid Cancer;Clinical Thyroidology;2022-02-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3